Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)

RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)

US Patent 10407682 · Granted Sep 10, 2019

Estimated economic value: $1,880,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Systems and methods for water production, treatment, adjustment and storage2025
Thermal desiccant systems and methods for generating liquid water2025
Integrated circuits for driving transducers2025
Therapeutic compositions for treating pain via multiple targets2024
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene 2024
Symmetric layout for high-voltage amplifier2024
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated2022
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene 2022
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression 2020
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression 2020
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression 2020
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated2020